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Abstract 
The aim of this study was to analyze the relative and differential efficacy of a combined 
versus medical treatment to reduce the symptoms of ADHD children in the school and 
family environment.  
A total of 100 subjects participated: 20 children with ADHD, their 40 parents and their 
40 teachers. Half of the subjects were assigned to the drug group and half to the 
combined (drug plus psychosocial, psychoeducational intervention with teachers and 
parents / mothers).  
Results: The group analyses indicated that both treatments were effective, without 
significant differences between them. Individualized clinical analyses indicated that 
higher percentages of improvement and normalization were obtained in the children in 
the combined group than in the drug only group. Our findings point to the desirability of 
implementing multimodal, multicontextual interventions, and long-lasting for ADHD in 
childhood.  
Keywords: ADHD children; multimodal treatment; methylphenidate; psychosocial 
treatment; training teachers. 
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1. Introduction 
ADHD is a neurodevelopmental disorder characterized by inattention, 
impulsivity and/or motor activity, which significantly interfere in the social, 
emotional and cognitive levels of affected children in their natural developmental 
contexts (APA, 2013; Cardo & Servera, 2008). 
Its high prevalence, along with its negative impact, frequent comorbidity and 
chronic nature, make it one of the most researched and treated childhood disorders 
in the last decade. Indeed, the number of children diagnosed with ADHD increased 
by 24% from 2001 to 2010 (Getahun, 2013) so that between 3% and 7% of school-
age children present the disorder (Cardo, Servera, Vidal, De Azúa, Redondo & 
Riutort, 2011; Polanczyk et al., 2007). Often associations with behavioral problems, 
learning difficulties, socio-affective deficits and risk behaviors occur (Humphreys et 
al., 2013; McQuade et al., 2011; Sexton et al., 2012). 
The etiology of ADHD is multifactorial. Its origin is genetic and 
neurobiological, but its clinical course and prognosis are greatly influenced by 
environmental factors (Bralten et al., 2013; Del Campo, Chamberlain, Sahakian & 
Robbins, 2011; Owens & Hinshaw, 2013). In keeping with the nature of the 
disorder, interventions that have been validated empirically include 
psychostimulants, psychosocial interventions, and treatments that combine both 
types of intervention (Coghill et al., 2013; Gerber et al., 2012; American Academy 
of Pediatrics, 2011). 
Stimulant medication, in the form of methylphenidate, is the pharmacological 
treatment of choice for managing ADHD, having been endorsed by hundreds of 
efficacy studies to reduce core symptoms and difficulties in cognitive function 
(Charach & Fernández, 2013; Coghill et al., 2013; Scheweren et al., 2012). 
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These benefits are generally maintained over several years, although most 
children relapse when medication is discontinued (Abikoff et al., 2004; Charack et 
al., 2004; Buitelaar et al., 2007; Swanson et al., 2008). 
The potential benefits of psychostimulants in the short term must be weighed up 
against their limitations and risks, such as adverse side effects, especially in 
preschool children (González de Dios, Cardo & Servera, 2006; Swanson, Elliott, 
Greemhill, Wigal, Arnold &Vitiello, 2007; Swanson et al., 2008; Charach, Carson, 
Fox, Ali, Beckett & Lim, 2013; Ghuman, Arnold & Anthony, 2008). 
Moreover, medication dropout rates ranging from 13% to 64% have been 
observed, especially in immediate action stimulants (Adler & Nierenberg, 2010). 
These drawbacks justify the implementation of psychosocial interventions that 
have been empirically validated as parents’ and teachers’ training in behavior 
management techniques, and cognitive behavioral techniques (Arco, Fernández & 
Hinojo, 2004; Fabiano, Pelham, Coles & Gnagy, 2009; Hodgson, Hutchinson & 
Denson, 2014; Miranda, Jarque & Tárraga, 2006; Presentación, Siegenthaler, Jara & 
Miranda, 2010; Chronis et al., 2006; Pelham & Fabiano, 2008). 
In the school environment, these interventions were shown to be effective in 
reducing the core symptoms of ADHD, difficulties in cognition, and disruptive and 
aggressive behaviors (Miranda et al., 2011; Antshel & Barkley, 2008; Miranda, 
Jarque & Rosel, 2006). They have also have been shown to be effective in 
increasing academic productivity, social competence and rules compliance (Abikoff 
et al., 2013). 
Similarly, in the family context various training programs for parents of children 
with ADHD have been implemented, and were found to be effective in reducing the 
core symptoms and family distress, and improving parenting skills (Ferrin et al., 
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2013; Fabiano, Pelham, Coles & Gnagy, 2009; Jones, Daley, Hutchings, Bywater & 
Eames, 2008; Mikami, Lerner, Griggs, McGrath & Calhoun, 2010). 
Moreover, studies that have implemented psychosocial intervention programs in 
both settings have shown they can result in more successful outcomes than its use 
alone (Miranda et al., 2011; Siegenthaler, 2009). 
However, as with medication, these interventions are not exempt from 
limitations, including limited evidence of maintenance of the improvements, or the 
generalization of learned behavior in other situations (Fabiano, Pelham, Coles & 
Gnagy, 2009). 
In addition, dropout rates in these cases are also high, reaching up to 50%, 
particularly in parents suffering a lot of stress, who do not agree with the principles 
of training, or who perceived their child as a difficult person and/or with severe 
behavior problems (Friars & Mellor, 2007). 
Recognizing the limitations of both interventions applied in isolation, different 
clinical practice guidelines on ADHD support the use of multimodal treatments 
(American Academy of Pediatrics, 2001; Grupo de trabajo de la guía de práctica 
clínica sobre el TDAH del Sistema Nacional de Salud, 2010; Institute for Clinical 
Systems Improvement, 2007; National Institute for Health and Clinical Excellence, 
2009). 
Along this vein, some studies have found that the dose of medication can be 
reduced when prescribed in combination with psychosocial interventions whilst 
obtaining the same results. Furthermore, a reduction of the possible side effects of 
long-term medication is also observed (Antshel & Barkley, 2008; Van der Oord et 
al., 2012; Pelham, Burrows, Gnagy & Fabiano, 2005; So, Leung & Hung, 2008). 
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In conclusion, the three interventions that have shown efficacy are 
pharmacological, psychosocial and combined. However, there are still few studies 
that have compared the differential effectiveness of these interventions, at least in 
our country, Spain. 
Indeed, the objective of this research was to analyze the effects of a combined 
intervention versus pharmacological treatment in reducing the core symptoms of 
ADHD children in the school and family environment.  
 The specific objectives and hypotheses of this study are: 
1.  To analyze the relative and differential efficacy of pharmacological intervention 
versus a combined one on the core symptoms of ADHD in the school 
environment. 
We hypothesized that both treatments would be effective, but that the combined 
intervention would produce a significantly greater reduction in symptoms 
compared with medication alone. 
2. To analyze the relative and differential efficacy of pharmacological intervention 
versus a combined one on the core symptoms of ADHD in the family 
environment. 
We hypothesized that both would be effective, but that the combined 
intervention would produce a significantly greater reduction in symptoms, 







2. Method  
2.1. Setting and participants 
This study involved three related samples (N = 100): a group of children with 
ADHD (N = 20), their families (parents/mothers, N = 40) and teachers (tutors, 
specialists, N = 40). 
Half of the children received stimulant medication exclusively, while the other 
half received a combined treatment (stimulant medication plus psychosocial 
intervention). 
Sample of children 
For the selection of children with ADHD, we collaborated with the 
psychoeducation teams of four concerted schools in Barcelona (Catalonia, Spain), 
who conducted the ADHD diagnoses. A total of 20 children with ADHD, whose 
demographic characteristics are shown in Table 1, participated in the study. Half of 
them were assigned to the group receiving drug treatment and the other half to the 
other, which received the combined intervention. 
(table 1 here) 
The 10 children in the “drug group” were selected from three concerted schools 
in Barcelona (Spain) with the cooperation of the educational and psychology teams, 
after informed consent and a commitment for participation of their families and 
teachers was obtained. The children were aged between 7 and 9 years (mean 7.6 
years), with a clear predominance of males over females (8/2). All of them were 
diagnosed with ADHD combined subtype by the psychology team and were not 
receiving any specific treatment. 
The sample comprising the combined treatment group consisted of 10 children 
from a concerted school of Barcelona (Spain) whose parents had provided informed 
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consent and commitment to participate in the study to the psychology team. The 
children were aged between 7 and 9 years (mean 7.8), with a clear predominance of 
males over females (9/1). 8 of them were diagnosed with ADHD combined 
subtype, 1 with inattentive subtype and 1 with hyperactive-impulsive subtype, none 
of whom were receiving treatment.  
 
Sample of parents 
The parent sample consisted of the 20 fathers and 20 mothers of the ADHD 
children described above. Half of the couples formed the drug group sample, and the 
other half, the combined group sample. Table 2 shows the sociodemographic 
characteristics of each group. 
(table 2 here) 
The parents of the children in the drug group sample had a mean age of 37.5 years and 
an average of 2.1 children per family. They belonged to a medium-high socioeconomic 
status and educational levels were heterogeneous (10%, basic studies; 25%, secondary 
education; 65%, university graduates). They were duly informed and agreed that, upon 
completion of the investigation, the school teachers would receive a refresher course in 
ADHD and families would receive multiple sessions of psychoeducational counseling 
(waiting list). 
 The parents of the children in the combined group had a mean age of 39.3 years 
and an average of 2.5 children per family. They belonged to a medium-high 
socioeconomic status and educational levels were heterogeneous (20%, basic studies; 
40%, secondary education; 40%, university graduates). All of them agreed to participate 
in the training program that would be implemented. 
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 Sample of teachers 
 In addition, 40 teachers also participated, half of them in the drug group and the 
other half in the combined group. All of them were primary school teachers, 20 of them 
being main teacher of children with ADHD, and the others, specialist teachers.  
As seen in Table 3, the average age of teachers in the pharmacological group 
was 40.3 years, with a clear predominance of women over men (16/4). 
(table 3 here) 
Teachers had an average of 23.5 years teaching experience and 45% had had 
some teaching experience with pupils with ADHD. None of the teachers had previously 
attended specialization courses on ADHD. 
On the other hand, the average age of the teachers in the combined group was 
38.4 years. There was also a clear predominance of women over men (13/7). They had a 
average of 19.1 years teaching experience and 60% had had some teaching experience 
with children with ADHD. Only one of the teachers had previously attended 
specialization courses on ADHD. 
 
2.2. Mesures 
The diagnosis of ADHD in the children was conducted by educational 
psychology teams working in their school. The specific criteria adopted to determine the 
presence of ADHD were those designated by the DSM-IV-TR (APA, 2000) as well as 
an IQ score equal to or greater than 80 in the Raven test. 
In addition, the ADHD Questionnaire (Amador, Forns, Guardia & Peró, 2005) 
was used in both the diagnostic process (pretreatment phase) and in the posttreatment 
phase in the two samples of children. This questionnaire includes the 18 symptoms 
defined by the DSM-IV-TR (2000) for ADHD. The wording of the items is the same as 
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in the DSM-IV-TR, except that it does not include the word “often”.  Instead, it includes 
a Likert rating ranging between 0 (never) to 3 (almost always). The first nine items of 
the questionnaire define the symptoms of inattention and 9 following items define the 
symptoms of hyperactivity-impulsivity. Indeed, confirmatory factor analysis found that 
the 18 ADHD symptoms are grouped into two types: inattention and hyperactivity-
impulsivity (Amador et al. (2005). Moreover, the reliability of the two types and the 
questionnaire, as measured by Cronbach’s alpha coefficient, was found to be high, with 
coefficients between 0.948 and 0.957. 
For each item, parents and teachers selected the answer that best fit the behavior 
under evaluation. To receive a diagnosis of ADHD, both parents and teachers had to 




Children started stimulant medication as prescribed by their pediatricians, and 
families and teachers of the combined group received parallel psychoeducational group 
training on ADHD. Treatment took place throughout the school year, excluding the 
student holiday periods. 
Pharmacological intervention 
Children of the drug group started their pediatrician’s prescribed treatment at the 
beginning of the school year. Specifically, 3 of them (30%) received quick-release 
methylphenidate in daily doses of 5 mg each before breakfast and lunch; 7 children 
(70%) received delayed-release methylphenidate in a single daily dose of 18 mg in the 
morning. During weekends they did not receive pharmacological treatment. 
 10 
Children of the combined group also began drug treatment at the start of the 
school year under the guidance of their pediatricians. Specifically, 4 patients (40%) 
were treated with quick-release psychostimulant medication and 6 (60%) delayed-
release methylphenidate. Like the drug group, they did not receive drug treatment at the 
weekend. 
Training Program for Teachers of Children with ADHD 
The program for teachers was conducted over 17 sessions of two hours, on a 
fortnightly basis. It was carried out over this extended period not only to provide 
teachers with intensive training in ADHD but to also give them practical advice 
throughout the academic year to help them manage issues in the classroom as they 
arose.  
The course consisted of 34 hours of continuous education by the school. The 
schedule was adjusted to the preferences of teachers, with sessions taking place after 
school hours (17.30); the venue was a classroom in the same school. These conditions 
greatly favored the attendance of the participants (98%). 
 The program was adapted from other empirically validated programs and 
materials developed by the ADANA Foundation and by the authors (Miranda, Jarque & 
Rosel, 2006; Mena, Nicolau, Salat, Tort & Romero, 2006). 
 The program was divided into seven thematic sections (see Picture 1) (Amado, 
Jarque, Signes, Acereda & López, 2014), which were: 1. Information on ADHD; 2. 
Forms of intervention in ADHD; 3. Strategies to improve behavior, and instructional 
management; 4. Strategies to adapt teaching and learning activities; 5. Strategies to 




Training Program for parents of children with ADHD 
The program for parents took place over nine sessions of two hours, on a 
monthly basis. The training was carried out over an extended period since our main 
objective was to improve the family functioning of these children and such a schedule 
allowed for sufficient time to assimilate, implement, review and automate strategies 
proposed throughout the program. 
All times were adjusted to parents’ preferences and sessions were conducted in 
such school conditions that favored high attendance of participants (97%).  
The program was adapted from other empirically validated programs and materials 
developed by the ADANA Foundation and by the authors (Barkley, 1997; Miranda, 
Grau, Meliá & Roselló, 2008). 
The program was divided into six thematic sections (see Picture 1) (Jarque & 
Amado, 2010), which were: 1 Presentation of the family; 2. ADHD in school; 3. ADHD 
in the family, and emotional implications; 4. ADHD in the family, and educational 
implications; 5. Communication Skills; 6. Skills for stress and conflict management; 
and 7. Closing session. 
(Picture 1 here) 
 
3. Results 
According to the objectives, we developed a mixed, quasi-experimental design 
(inter-group and intra-group), conducting assessments in the pretreatment and 
posttreatment phases. 
For statistical analyses, SPSS-17.0 software was used, with a confidence interval 
of 0.05 or less. 
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The effects of interventions (independent variables) on the core symptoms of 
ADHD in children (inattention, hyperactivity and impulsivity), both in the school and 
the family as measured by the ADHD Questionnaire, were analyzed (Amador et al., 
2005). 
Various statistical analyses of the data were performed. First, descriptive 
statistics were used to establish the sociodemographic characteristics of the participating 
samples, and the various means and standard deviations of the various measurements. 
Moreover, to perform inter-group and intra-group comparisons, nonparametric 
tests were applied since parametric conditions were not satisfied. The Wilcoxon test was 
used to perform comparisons between related samples (intra-group) between the 
pretreatment and posttreatment phases. Independent inter-group comparisons, that is, 
between the drug and combination groups, were also performed in both the pretreatment 
and posttreatment phases using the Mann Witney U test. 
Finally, in addition to group statistical analyses, individualized quantitative 
analyses were carried out by calculating the percentage of improvement for each child 
after treatment, according to scores of the ADHD Questionnaire given by parents and 
teachers (Amador et al., 2005; Bados & García, 2009). The percentage improvement is 
calculated by subtracting the posttreatment score from the pretreatment one and 
dividing the result by the pretreatment score. It is considered a significant improvement 
if the resulting percentage is equal to or greater than some arbitrary value, which varies, 





3.1. Results of the comparison of the effectiveness of treatments as estimated by 
teachers.  
 In the pretreatment phase, no significant inter-group differences were observed 
(see Table 4) (inattention: Z= -0.114, p= 0.909; hyperactivity: Z= -0.112, p= 0.911; 
impulsivity: Z= -0.270, p= 0.787). 
Furthermore, no significant differences between the two groups were observed 
postreatment (inattention: Z= -0.553; p= 0.580; hyperactivity: Z= -0.798; p= 0.425; 
impulsivity: Z= -1.845; p= 0.065) (see Table 4). 
(Table 4 here) 
 However, intra-group comparisons indicated that in the posttreatment phase a 
significant decrease is produced in the severity of symptoms of ADHD as estimated by 
teachers both in the drug group (inattention: Z= -3.774, p= 0.000; hyperactivity: Z= -
3.898, p= 0.000; impulsivity: Z= -3.5, p= 0.000) and the combined (inattention: Z= -
3.867, p= 0.000; hyperactivity: Z= -3.834, p= 0.000; impulsivity: Z= -2.530, p= 0.000) 
(see Table 5). 
(Table 5 here) 
With regard to individual analyses in the posttreatment assessments (see Tables 
6 and 7), improvements of between 20% and 55% were observed in the combined 
treatment group and between 0% and 42% in the drug-only group.  
The normalization data indicated that 20% of the children from the drug-only 
group were no longer considered to show ADHD symptoms, while this figure rose to 
30% in the combined group.   
 
(Table 6 here) 
(Table 7 here) 
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3.2 Results of the comparison of the effectiveness of treatments as estimated by 
parents. 
The results of the pretreatment assessments indicated that no differences were 
found between groups (inattention: Z= -1.633, p= 0.103; hyperactivity: Z= -0.070, p= 
0.944; impulsivity: Z= -0.277, p= 0.782) (see Table 8).  
Furthermore, no statistically significant differences between the groups were 
observed postreatment (inattention: Z= -1.633, p= 0.103; hyperactivity: Z= -1.522, p= 
0.128; impulsivity: Z= -0.172, p= 0.863) (Table 8). 
(table 8 here) 
However, intra-group comparisons indicated that in the posttreatment phase, a 
significant decrease occurred in the severity of symptoms of ADHD as estimated by 
parents in both the pharmacological group (inattention: Z= -3.345; p= 0.001; 
hyperactivity: Z= -3.508; p= 0.000; impulsivity: Z= -3.638; p= 0.000) (see Table 8), and 
the combined group (inattention: Z= -3.663; p= 0.000; hyperactivity: Z= -3.699; p= 
0.000; impulsivity: Z= -3.557; p= 0.000) (see Table 9). 
 (table 9 here) 
Regarding the individual analyses (see Tables 10 and 11), while children of the 
drug group achieved improvement percentages ranging from 0% to 40%, the combined 
group improved between 20% and 75%. 
The normalization data indicated that while only 20% of the children in the drug 
only group were considered to no longer show symptoms, in the combined group the 
percentage of normalized children as assessed by parents rose to 90%. 
(table 10 here) 
(table 11 here) 
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4. Discussion and conclusions  
The main objective of this study was to deepen our understanding of the relative and 
differential efficacy of combined versus pharmacological interventions for childhood 
ADHD in the school and family environment. 
The group results demonstrate that both intervention types are equally effective 
in reducing the core symptoms of ADHD in children in both settings after ten months of 
treatment. 
Our results partially confirm the initial hypotheses, namely that although both 
treatments were effective, the combined treatment was not significantly better than the 
drug-only treatment. 
Our findings are in the line with previous studies that compared the effects of 
different intervention procedures on childhood ADHD (The MTA Cooperative Group, 
1999, 2004; Van der Oord et al., 2007, 2008, 2012; Ercan et al., 2012). No statistically 
significant differences were observed between the combined and drug-only treatments.   
In the study carried out by the MTA Cooperative Group, preliminary analyses 
revealed that there were no significant differences between the combined and drug-only 
treatments in terms of their efficiency in reducing the core symptoms of ADHD after 14 
months and two years (MTA Cooperative Group 1999; 2004).  
The research by Van der Ord et al. (2007), which compared the effects of drug 
treatment with a multimodal therapy, including training for parents, teachers and 
children themselves, found that both are equally effective treatments. In a meta-analysis 
conducted later by the same authors (Van der Ord et al., 2008), they explained that these 
results could possibly be due to the sequencing of treatments and the dosage of 
methylphenidate used. For the core symptoms of ADHD, psychostimulant effects are 
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broad and leave little possibility for improvement when psychosocial treatment is 
subsequently incorporated. 
In a subsequent study, Van der Oord et al. (2012) also did not find any 
differences in the diagnostic status and symptoms in long-term ADHD after a combined 
or drug-only treatment in ADHD children. However, the adolescents who received the 
combined treatment received significantly less medication than those in the drug-only 
group in the 4.5 to 7.5 year follow-up phase. 
Ercan et al. (2014) also did not observe any significant improvements in the 
combined group versus the drug-only group. Thus, results revealed that no significant 
effects were observed on the severity of the symptoms after the inclusion of parent 
training in the MPH treatment.  
On the other hand, other studies support the significant superiority of the 
multimodal versus the drug-only treatment in reducing the core symptoms of ADHD in 
children (Swanson et al., 2001; Conners et al., 2001; Pelham et al., 2005; Bogdana et 
al., 2012).  
MTA authors conducted secondary analyses to explore the utility of a single, 
statistically derived composite measure of treatment outcome for the MTA trial. Data 
analyses revealed that a combined treatment was significantly better than all other 
treatments, with effect sizes ranging from a small to moderately large (Conners et al., 
2001; Swanson et al., 2001). The authors explained that when the precision of the 
measurement was increased, a statistically significant increase in the combined 
treatment over the drug-only treatment was detected.  
Pelham et al. (2005) also analyzed the differences in the efficacy of a combined 
versus drug-only treatment and observed a significant improvement in the combined 
treatment in a summer treatment program. The author suggest that the low doses of 
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MPH, which were even lower than in previous studies, yielded enhanced effects in 
combination with behavior modification.  
Bogdana et al. (2012) also observed that a multimodal intervention proved to be 
more effective than medication alone in ameliorating the child’s social behavior in both 
the family and school environment with regards to the main ADHD symptoms. 
The second part of our results was obtained from individualized clinical 
analyses. After carrying out individualized data analysis, clinically important 
differences were found. Specifically, with regard to the percentage improvement, both 
parents and teachers were of the opinion that all the ADHD children who received a 
combined treatment showed signs of clinical improvement in the core symptoms of 
ADHD.  
However, with regard to the drug-only treatment, 10% of the children did not 
show any clinical improvement in the core symptoms in the opinion of the teachers. 
Furthermore, according to the parents, 30% of the children failed to show clinical 
improvements in attention, with 20% of the children showing no improvement in the 
hyperactivity-impulsivity symptoms.  
With regard to the normalization data, the results reveal that improvements were 
greater in the combined group, especially in the opinion of the parents: 90% no longer 
displayed clinical symptoms after receiving a combined treatment. One possible 
explanation for this may be the emphasis given to the reduction in family distress 
through training in emotional and communication strategies in the parental intervention 
program. 
Finally, when we analyze our normalization and clinical improvement results in 
each of the children integrated into the school and family context, we also found that the 
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highest percentage of improvement and normalization occurred in the children who 
followed the combined intervention.  
Our clinical results are consistent with those obtained by other authors who have 
supported the superiority of combined treatment to any single treatment in normalizing 
behavior, as well as in achieving higher rates of improvement in children with ADHD 
(Conners et al., 2001; Swanson et al., 2001; So et al., 2008). 
So et al. (2008) also found higher proportions of children with ADHD of the 
combined treatment group who met the criteria for normalization posttreatment, even 
with lower doses of medication. 
The first results produced by the MTA Cooperative Group revealed that at the 
end of the study a similar number of children from both the combined and drug-only 
groups no longer met the criteria for ADHD (combined: 90%; pharmacological: 88%) 
(MTA, 1999). 
To supplement the primary analyses, the MTA investigators developed and 
analyzed a qualitative outcome measure of success to explore the study’s clinical 
relevance and practical significance (Swanson et al., 2001). Specifically, each subject 
was evaluated at the end of the study with the SNAP scale developed by Swanson et al. 
(2001), which evaluates the core symptoms of ADHD and ODD as defined by DSM-IV, 
and which was completed by parents and teachers. The results revealed a small to 
moderate improvement in the combined treatment versus drug-only. The multimodal 
treatment resulted in a 12% improvement over the pharmacological treatment. Logistic 
regression analyses were used to compare success rates for the treatments. The results 
showed the following proportions of children that were normalized in each of the 
groups: combined (68%), pharmacological (56%), behavioral (34%), and routine 
community care (25%).  
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Furthermore, the psychosocial intervention in the MTA study was discontinued 
in the behavioral and combined treatments whilst continuing with the medication, which 
may have resulted in a bias in the results, favoring the effects of the drug-only treatment 
(Swanson et al., 2001).  
Finally, a follow-up analysis of the MTA study at 6 and 8 years revealed that the 
there was no significant difference between the treatment groups in terms of the core 
symptoms of ADHD possibly as a result of the changes in the medication procedure, in 
that some of the children stopped taking it whilst others started taking it (Jensen et al., 
2007; Molina et al., 2008). The authors also postulate that the differences in the effects 
of the treatments can be seen when the treatments are in progress but diminish when the 
intensity of treatment is reduced (Molina et al., 2009). 
4.1. Strengths and limitations 
Although our results are positive, our study has a number of limitations that 
could be improved upon in future studies. Firstly, the small sample size has meant that 
we have had to carry out nonparametric statistical analyses, which may have a lower 
discrimination power. 
Secondly, parents and teachers are active agents in the intervention and at the 
same time evaluators of their results, which could lead to some kind of bias.  
Finally, we do not have any follow-up data that helps us to discriminate the 
effects of long-term intervention and differentiate between the improvements brought 
about by the child’s development. 
In future studies, it would be useful to extend the sample size, collecting 
additional data from other evaluators and performing follow-up analyses. 
However, despite these limitations, our study provides valuable information 
regarding the efficacy of a multimodal, multicontextual and long-lasting intervention to 
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improve the core symptoms of ADHD in children. One of the most important 
conclusions derived from our study is the superiority of the multimodal intervention 
versus an exclusively pharmacological treatment to normalize the behavior of children 
with ADHD in their everyday contexts. These findings allow us to maintain a hopeful 
attitude about the possibilities that this type of intervention may offer. 
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Session PARENTS Session TEACHERS 
September 0 Presentation and organization 0 ADHD seminar 
October 1 I INTRODUCE MYSELF: My child 
and I 
1 I INTRODUCE MYSELF: My student 
and I 
   2  
 
I KNOW IT AND I UNDERSTAND: 




I KNOW IT AND I UNDERSTAND: 
Knowledge about ADHD 
 
3 
   4 
December  
3 
ADHD IN SCHOOL: Difficulties in 




WHAT WE CAN DO 





I VALUE HIM/HER POSITIVELY, she 
values and reinforces him/herself  
January 4  
ADHD IN MY FAMILY: Emotional 
implications 
7 
  8 
February 5 9 I ORGANIZE HIM/HER, s/he organizes 
him/herself and s/he listens   10 
March 6 ADHD IN MY FAMILY: 
Educational implications 
11  
I ADAPT the classroom and activities    12 
April 7  
I IMPROVE MY 
COMMUNICATION 
13  
WE BUILD BRIDGES 
   14 
May 8  
I IMPROVE MY SELF CONTROL 
15  
I IMPROVE MY SELF CONTROL 
   16 
June 
 
9 FAREWELL: what I take with me 17 FAREWELL: what I take with me 
Hours 18  34  
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Table 4. Intergroup comparison of the perception of the symptoms of ADHD as estimated by teachers in 








 Average DT Average DT Z p 
PRE 
TREATMENT 
      
Inattention 7.05 1.70 7.00 1.74 -0.114 0.909 
Hyperactivity 5.05 1.09 5.1 1.16 -0.112 0.911 





Inattention 5.2 3.8 5.05 0.887 -0.553 0.580 
Hyperactivity 3.8 0.83 3.55 0.887 -0.798 0.425 
Impulsivity 1.6 0.59 1.90 0.447 -1.845 0.065 


























































Table 5. Intragroup comparison of the perception of ADHD symptoms as estimated by the teachers of the 
pharmacological and combined groups. 
 PRETEST  POSTEST     
 Average DT Average DT Z p d 
PHARMACOL.        
Inattention 7.05 1.70 5.2 0.89 -3.774 0.000** 1.08 
Hyperactivity 5,05 1.09 3.8 0.83 -3.898 0.000** 1.14 
Impulsivity 2.3 0.65 1.6 0.59 -3.5 0.000** 1.07 
 
COMBINED 
       
Inattention 7.00 1.74 5.05 0.887 -3.867 0.000** 1.12 
Hyperactivity 5.1 1.16 3.55 0.887 -3.834 0.000** 1.33 
Impulsivity 2.35 0.67 1.90 0.447 -2.530 0.000** 0.67 




















































Table 6. Percentage improvement as estimated by teachers in pharmacological group of ADHD symptom 
of each child according to the DSM-IV-TR (APA, 2000). 
 












1 7 5 28 
 6 5 16 
2 7 5 28 
 7 6 14 
3 6 5 16 
 7 6 14 
4 7 6 14 
 6 6 0 
5 6 6 0 
 6 6 0 
6 6 6 0 
 8 7 12 
7 7 4 42 
 8 7 12 
8 6 5 16 
 8 5 37 
9 9 6 33 
 6 4 33 
10 7 6 14 


























Table 7. Percentage improvement as estimated by teachers in the combined group of ADHD symptoms of 
each child according to the DSM-IV-TR scale (APA, 2000). 
 












1 8 5 37 
 9 6 33 
2 9 6 33 
 5 3 40 
3 8 4 50 
 8 5 37 
4 9 4 55 
 8 6 25 
5 9 5 44 
 9 6 33 
6 9 5 44 
 8 6 25 
7 8 6 25 
 8 4 50 
8 9 4 55 
 9 4 55 
9 6 4 33 
 9 6 33 
10 5 4 20 





































Average DT Average DT Z p 
PRE TREATMENT       
Inattention 7.05 1.70 6.35 2.20 -1.633 0.103 
Hyperactivity 5.05 1.09 4.60 1.50 -0.070 0.944 
Impulsivity 2.3 0.65 2.20 0.61 -0.277 0.782 
 
POST TREATMENT 
Inattention 5.05 1.43 4.35 1.42 -1.633 0.103 
Hyperactivity 3.50 1.14 3.0 0.91 -1.522 0.128 
Impulsivity 1.45 0.60 1.45 0.51 -0.172 0.863 
































Table 9. Intragroup comparison of ADHD symptoms as estimated by parents of the pharmacological and 
combined treatment groups. 
 PRETEST POSTEST    
Average DT Average DT Z p d 
PHARMACOL.        
Inattention 6.35 2.20 5.05 1.43 -3.345 0.001** 0.59 
Hyperactivity 4.60 1.50 3.50 1.14 -3,508 0.000** 0.73 
Impulsivity 2.20 0.61 1.45 0.60 -3.638 0.000** 1.22 
 
COMBINED 
       
Inattention 6.15 2.34 4.35 1.42 -3.663 0.000** 0.76 
Hyperactivity 4.60 1.53 3.0 0.91 -3.699 0.000** 1.04 
Impulsivity 2.25 0.63 1.45 0.51 -3.557 0.000** 1.26 






















































Table 10. Percentage improvement as estimated by parents in pharmacological group of ADHD 
symptoms of each child according to the DSM-IV-TR scale (APA, 2000). 
 
 













1 6 5 16 
 6 4 33 
2 5 5 0 
 8 6 25 
3 6 5 16 
 6 6 0 
4 9 6 33 
 5 4 20 
5 8 6 25 
 8 6 25 
6 5 5 0 
 7 5 28 
7 2 2 0 
 8 6 25 
8 5 3 40 
 7 7 0 
9 9 6 33 
 5 4 20 
10 6 4 33 




















Table 11. Percentage improvement as estimated by parents in the combined group of ADHD symptoms of 
each child according to the DSM-IV-TR scale (APA, 2000). 
A 













1 6 4 33 
 9 5 44 
2 9 6 33 
 5 3 40 
3 7 3 57 
 9 4 55 
4 3 2 33 
 9 4 55 
5 6 3 50 
 8 4 50 
6 9 5 44 
 9 5 44 
7 9 5 44 
 5 4 20 
8 8 4 50 
 8 2 75 
9 5 2 60 
 8 5 37 
10 7 4 42 
 7 3 57 
 
